Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $21,345 | $20,119 | $18,781 | $16,745 |
| - Cash | $432 | $319 | $188 | $549 |
| + Debt | $6,382 | $6,384 | $6,570 | $6,925 |
| Enterprise Value | $27,295 | $26,184 | $25,163 | $23,121 |
| Revenue | $2,816 | $2,761 | $2,652 | $2,621 |
| % Growth | 2% | 4.1% | 1.2% | – |
| Gross Profit | $949 | $943 | $863 | $858 |
| % Margin | 33.7% | 34.2% | 32.5% | 32.7% |
| EBITDA | $547 | $596 | $488 | $507 |
| % Margin | 19.4% | 21.6% | 18.4% | 19.3% |
| Net Income | $245 | $282 | $220 | $222 |
| % Margin | 8.7% | 10.2% | 8.3% | 8.5% |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.95 |
| % Growth | -12.6% | 27.3% | -0.5% | – |
| Operating Cash Flow | $563 | $544 | $314 | $464 |
| Capital Expenditures | -$144 | -$108 | -$117 | -$123 |
| Free Cash Flow | $419 | $436 | $197 | $341 |